Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3

Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3

Abstract Background Bleeding in people with hemophilia A can be life threatening, and intra‐articular bleeds can result in joint damage. Most clinical studies focus on treated bleeds, while bleeds not treated with coagulation factor(s) (untreated bleeds) are underreported. Objectives We assessed the...

Full description

Bibliographic Details
Main Authors: Michael U. Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse‐Jarres, Víctor Jiménez‐Yuste, Midori Shima, Peter Trask, Christine L. Kempton, Craig M. Kessler, Gallia G. Levy, Flora Peyvandi
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
bleeding
factor VIII
hemophilia A
hemostasis
prophylaxis
Online Access:https://doi.org/10.1002/rth2.12782

Internet

https://doi.org/10.1002/rth2.12782

Similar Items